Document |
Document Title |
WO/2024/080748A1 |
The present invention provides a novel compound and an organic light emitting device comprising same.
|
WO/2024/054685A3 |
This invention is directed to botanical compositions comprising plant extracts and methods of preparing the same.
|
WO/2024/079351A1 |
The present invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof. The invention further relates to the use of the compounds of the invention as neuroprotective and/or neurore...
|
WO/2024/079091A1 |
The present invention relates to the field of biomass waste feedstock conversion into value-added chemicals. Specifically, the present invention relates to a method production of a chemical derived from biomass or derived from a biomass-...
|
WO/2024/077350A1 |
Disclosed herein is A process for producing levoglucosenone and/or chloromethylfurfural from biomass comprising cellulosic and/or hemicellulosic material, the process comprising subjecting the biomass to a first thermal treatment at a te...
|
WO/2024/078612A1 |
A linker-payload compound for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof are provided.
|
WO/2024/081748A2 |
Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, R2, R3, R5, R6, R7, R8, R9, R10, R11a, R12b, and X are as defined elsewher...
|
WO/2024/080128A1 |
The present invention addresses the problem of providing an actinic ray-sensitive or radiation-sensitive resin composition from which a resist pattern having a small LWR can be formed. An actinic ray-sensitive or radiation-sensitive resi...
|
WO/2024/011131A3 |
This application discloses novel tandem dehydrogenation-olefination-lactonization reactions for the preparation of β-alkylidene-γ-lactones using bidentate oxime ether-pyridone and morpholine-pyridone ligands for β,γ-dehydrogenation a...
|
WO/2024/078137A1 |
An organic electroluminescent device and an electronic apparatus. The organic electroluminescent device comprises a cathode, an anode, and an organic layer, the organic layer comprises an organic light-emitting layer, and the organic lig...
|
WO/2024/079704A1 |
THIS invention relates to the synthesis of derivatives of siphonochilone and therapeutic use thereof in the treatment and prevention of respiratory virus disease, in particular influenza or a coronavirus disease.
|
WO/2024/081714A2 |
Disclosed herein are new inhibitors of GroEL/ES and HSP60/10 chaperonin systems that serve as new antibiotic candidates against a variety of infectious organisms. The identified compounds can selectively kill Escherichia coli, the ESKAPE...
|
WO/2024/075825A1 |
The present invention addresses the problem of providing a novel compound that has an OX2R agonist activity. The present invention pertains to a cyclopentane compound represented by formula (I) or a pharmacologically acceptable salt th...
|
WO/2024/076117A1 |
The present invention is an organic compound used in an organic layer provided in an organic light-emitting element. In particular, when the organic compound is used in an electron blocking layer of an organic light-emitting element, it ...
|
WO/2024/071281A1 |
The purpose of the present invention is to provide: a novel asymmetric fluorinated allyl compound that can be induced to various bioactive medium-sized molecules, and that has high optical purity; and a method for producing the same. Asy...
|
WO/2024/073348A1 |
An integrated process for making furan-2,5-dicarboxylic acid (FDCA) and FDCA derivatives combines a furfural oxidation reaction, an intermediate water removal step, and a furoate salt carboxylation reaction. A furfural feed stream is oxi...
|
WO/2024/067610A1 |
The present application provides a method for preparing L-glufosinate. The method mainly comprises the following steps: addition and rearrangement and ring-opening reactions on a ring lactone with a substituted phosphate-type phosphine r...
|
WO/2024/073347A1 |
A process for making furfural, derivatives of furfural, or both from biomass is described. The biomass feed is optionally conditioned to obtain a moisture content of 25 wt% or less. The biomass feed is ground to form particles having a p...
|
WO/2024/071771A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
WO/2024/071951A1 |
The present invention relates to a 5-halomethylfurfural production method involving a pretreatment step and, specifically, to a 5-halomethylfurfural production method whereby the yield of halomethylfurfural can be maximized by performing...
|
WO/2024/070968A1 |
Provided are: an actinic ray-sensitive or radiation-sensitive resin composition containing (A) a resin the polarity of which is increased due to acid activity, (B) a compound which produces an acid when irradiated with actinic rays or ra...
|
WO/2024/071770A1 |
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.
|
WO/2024/073364A1 |
Provided here is a combination comprising (i) Compound A having the name of 1-((1S,1aS,6bS)-5-((7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridi
n-4-yl)oxy)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-1-yl)-3
- (2,4,5-trifluorophenyl) urea, or the ...
|
WO/2024/065968A1 |
A method for continuously synthesizing 5-hydroxymethylfurfural by using a micro-channel reactor, which belongs to the technical field of micro-chemical engineering. The method comprises: separately conveying an aqueous glucose solution, ...
|
WO/2024/062180A1 |
The invention relates to a compound for preparing a gel of formula (I): wherein the groups R1, R2, R3 and R4 are independently selected from among: a hydrogen; a group selected from between at least one aromatic group and a heteroaromati...
|
WO/2024/063019A1 |
Provided are: an amino compound represented by general formula (1); a method for producing the amino compound; an epoxy resin curing agent comprising the amino compound; an epoxy resin composition; and a cured product of the epoxy resin ...
|
WO/2024/063093A1 |
The purpose of the present invention is to provide an ester-compound-containing composition that has excellent storage stability and a method for producing the same, and methods for producing a polymerizable composition and a (meth)acryl...
|
WO/2024/062084A1 |
Process for producing 2,5-furandicarboxylic acid which process comprises (i) contacting in an oxidation unit a furan derivative with oxidant and solvent in the presence of a catalyst system to obtain intermediate product comprising 2,5-f...
|
WO/2024/063018A1 |
Provided are: an amino composition comprising an amino compound (A) represented by general formula (1) and an amino compound (B) represented by general formula (3), in which the molar ratio [(A)/(B)] of the amino compound (A) to the amin...
|
WO/2024/059951A1 |
This invention provides compound having a structure of Formulas I-VI. Uses of such compounds for treatment of various indications that would benefit from modulation of the androgen receptor, including prostate cancer. Also provided are m...
|
WO/2024/056101A1 |
The present invention relates to a linker for an antibody-drug conjugate and a use thereof. Specifically, a linker represented by formula I is provided. An antibody-drug conjugate prepared by means of the linker are more stable and more ...
|
WO/2024/057249A1 |
The present invention relates to an improved process for the preparation of sulfonylurea based compounds of general formula (I). More specifically present invention provides an improved process for the preparation of compound of formula ...
|
WO/2024/055658A1 |
The present invention belongs to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element, and an electronic device. The structure of the nitrogen-containing compound is represented by ...
|
WO/2024/049017A1 |
The present invention relates to an organic semiconductor compound with high transmittance in the visible light spectrum and a use thereof.
|
WO/2024/046253A1 |
Provided in the present invention are a sodium channel regulator and the use thereof. The sodium channel regulator of the present invention has a brand-new structure and has an excellent in-vitro inhibitory effect on Nav 1.8. The compoun...
|
WO/2024/048481A1 |
Provided are a composition, and a resin composition and cured product using the composition. The composition includes an amino group and a cyclic ether structure, and contains a compound having a molecular weight of 1000 or less, and a l...
|
WO/2024/047227A1 |
The present invention relates to compounds of Formula (I) and (II) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical c...
|
WO/2024/043108A1 |
A photocurable composition containing a coloring agent, a radical polymerization initiator represented by formula (1) and a radically polymerizable compound; a method for producing a cured film using the photocurable composition; a film;...
|
WO/2024/043334A1 |
The present invention addresses the problem of providing a compound and pharmaceutical composition that possesses inhibitory activity against the drug efflux pumps of drug-resistant bacteria and, when used in combination with another dru...
|
WO/2024/039095A1 |
The present specification relates to a heterocyclic compound represented by chemical formula 1, an organic light-emitting element comprising same, and a composition for an organic layer.
|
WO/2024/038306A1 |
The present invention relates to a low-cost and facile process for the catalytic production of mycophenolate mofetil. Direct reaction of mycophenolic acid with 2-morpholinoethanol in a suitable solvent under azeotropic separation of wate...
|
WO/2024/039119A1 |
The present invention provides: a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electric element using same; and an electronic device thereof.
|
WO/2024/035085A1 |
The present invention relates to a novel compound, and a composition for preventing or treating HER2-positive cancer, comprising same. The novel compound of the present invention can suppress the level of HER2 by inhibiting the protein-p...
|
WO/2024/033884A1 |
An objective of the present invention is to provide, as a material for an organic electroluminescence (EL) element having high efficiency and high durability, an organic compound represented by general formula (I) and having excellent ho...
|
WO/2024/034659A1 |
Provided are an organic electroluminescent element having further improved element performance and an electronic appliance including such organic electroluminescent element. Specifically, provided are a compound represented by formula (1...
|
WO/2024/031242A1 |
A method for synthesizing an aryl benzyl thioether compound using photocatalysis. By using the iron (III) complex [HIMXy Me][FeBr 4]([HIMXy Me]=l,3-bis(4-methoxy-2,6-dimethylphenyl)-4,5-dimethylimidaz
olium cation) as a catalyst, fac-Ir(...
|
WO/2024/033677A1 |
The object of the invention relates to a method for the synthesis of 3-acetamide-furfural of formula I by using N-acetylglucosamine as starting material. 3-Acetamide-furfural can be seen as a valuable intermediate for the production N-co...
|
WO/2024/026596A1 |
Disclosed in the present invention is a novel method for synthesizing α-linear alkyl substituted heteroarene. In the presence of organic alkali, α-linear alkyl substituted heteroarene is synthesized by a hydroheteroarylation reaction o...
|
WO/2024/025151A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrod...
|
WO/2024/026290A1 |
The present invention relates to compounds, pharmaceutically acceptable salts of the compounds, and pharmaceutical compositions of the compounds, or salts thereof, that can inhibit secreted phospholipases A2 (sPLA2-X) enzymes, wherein th...
|